World Leaders' Usage of Twitter in Response to the COVID-19 Pandemic: a Content Analysis
Overview
Authors
Affiliations
Background: It is crucial that world leaders mount effective public health measures in response to COVID-19. Twitter may represent a powerful tool to help achieve this. Here, we explore the role of Twitter as used by Group of Seven (G7) world leaders in response to COVID-19.
Methods: This was a qualitative study with content analysis. Inclusion criteria were as follows: viral tweets from G7 world leaders, attracting a minimum of 500 'likes'; keywords 'COVID-19' or 'coronavirus'; search dates 17 November 2019 to 17 March 2020. We performed content analysis to categorize tweets into appropriate themes and analyzed associated Twitter data.
Results: Eight out of nine (88.9%) G7 world leaders had verified and active Twitter accounts, with a total following of 85.7 million users. Out of a total 203 viral tweets, 166 (82.8%) were classified as 'Informative', of which 48 (28.6%) had weblinks to government-based sources, while 19 (9.4%) were 'Morale-boosting' and 14 (6.9%) were 'Political'. Numbers of followers and viral tweets were not strictly related.
Conclusions: Twitter may represent a powerful tool for world leaders to rapidly communicate public health information with citizens. We would urge general caution when using Twitter for health information, with a preference for tweets containing official government-based information sources.
Izquierdo-Condoy J, Arias-Intriago M, Mosquera-Quinonez M, Melgar Munoz F, Jimenez-Ascanio M, Loaiza-Guevara V Med Educ Online. 2025; 30(1):2474129.
PMID: 40055918 PMC: 11892066. DOI: 10.1080/10872981.2025.2474129.
Alshanik F, Khasawneh R, Dalky A, Qawasmeh E JMIR Infodemiology. 2025; 5:e53434.
PMID: 39928401 PMC: 11851025. DOI: 10.2196/53434.
Incorporating connectivity among Internet search data for enhanced influenza-like illness tracking.
Ning S, Hussain A, Wang Q PLoS One. 2024; 19(8):e0305579.
PMID: 39186560 PMC: 11346739. DOI: 10.1371/journal.pone.0305579.
Bishal M, Chowdory M, Das A, Kabir M Heliyon. 2024; 10(14):e34103.
PMID: 39100452 PMC: 11295851. DOI: 10.1016/j.heliyon.2024.e34103.
Chepo M, Martin S, Deom N, Khalid A, Vindrola-Padros C J Med Internet Res. 2024; 26:e50139.
PMID: 38630514 PMC: 11063881. DOI: 10.2196/50139.